These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31964167)

  • 1. Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world data.
    Seewald MJ; Plumb JM; Gutierrez B; Liwing J; Tepie MF; Hammer M; LoCasale R; Khosla S; Yin D; Pashos CL; Nagy M
    J Comp Eff Res; 2020 Feb; 9(3):155-159. PubMed ID: 31964167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging the Gap Between RCTs and RWE Through Endpoint Selection.
    LoCasale RJ; Pashos CL; Gutierrez B; Dreyer NA; Collins T; Calleja A; Seewald MJ; Plumb JM; Liwing J; Tepie MF; Khosla S
    Ther Innov Regul Sci; 2021 Jan; 55(1):90-96. PubMed ID: 32632753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings.
    Sun F; Bedenkov A; Liu BC; Yang J; Xu JF; Ji L; Zhou M; Zhang S; Li X; Song Y; Chen P; Moreno C
    Pharmaceut Med; 2024 May; 38(3):157-166. PubMed ID: 38573457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare.
    Horgan D; Borisch B; Cattaneo I; Caulfield M; Chiti A; Chomienne C; Cole A; Facey K; Hackshaw A; Hendolin M; Georges N; Kalra D; Tumienė B; von Meyenn M
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust.
    Oehrlein EM; Graff JS; Harris J; Perfetto EM
    Patient; 2019 Aug; 12(4):375-381. PubMed ID: 30666526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated.
    Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ
    Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
    Orsini LS; Monz B; Mullins CD; Van Brunt D; Daniel G; Eichler HG; Graff J; Guerino J; Berger M; Lederer NM; Jonsson P; Schneeweiss S; Wang SV; Crown W; Goettsch W; Willke RJ
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1504-1513. PubMed ID: 32924243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partnerships in Pharma--An Economist Intelligence Unit Seminar--Building Innovation into Alliances and Business Models. 1 October 2010, London, UK.
    Kibble A
    IDrugs; 2010 Dec; 13(12):813-5. PubMed ID: 21154130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions.
    Akhras KS; Alsheikh-Ali AA; Kabbani S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):245-250. PubMed ID: 30626231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.
    Hiramatsu K; Barrett A; Miyata Y;
    Drugs Real World Outcomes; 2021 Dec; 8(4):459-480. PubMed ID: 34148219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sharing whilst caring: solidarity and public trust in a data-driven healthcare system.
    Horn R; Kerasidou A
    BMC Med Ethics; 2020 Nov; 21(1):110. PubMed ID: 33143692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Medical Affairs Leaders Who Create the Future.
    Bedenkov A; Rajadhyaksha V; Beekman M; Moreno C; Fong PC; Agustin L; Odell S
    Pharmaceut Med; 2020 Oct; 34(5):301-307. PubMed ID: 32949352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging the power of partnerships: spreading the vision for a population health care delivery model in western Kenya.
    Mercer T; Gardner A; Andama B; Chesoli C; Christoffersen-Deb A; Dick J; Einterz R; Gray N; Kimaiyo S; Kamano J; Maritim B; Morehead K; Pastakia S; Ruhl L; Songok J; Laktabai J
    Global Health; 2018 May; 14(1):44. PubMed ID: 29739421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evidence for coverage decisions: opportunities and challenges.
    Hampson G; Towse A; Dreitlein WB; Henshall C; Pearson SD
    J Comp Eff Res; 2018 Dec; 7(12):1133-1143. PubMed ID: 30411972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.